A confluence of healthcare trends has expanded a lucrative, if challenging, opportunity for pharmacies able to invest in its potential.
Rather than take vacation for Christmas and New Year’s, the editors of DSN worked to compile a list of the top 10 trends that will shake up the business in 2014.
A pharmacy professor and compounding pharmacy owner are candidates for president-elect of the American Pharmacists Association for 2015-2016, the group said.
Bi-Lo and Winn-Dixie will cover initial prescription costs for customers who have enrolled in the health insurance marketplaces, but don't yet have their identification cards, the chains said.
Forest Labs will buy privately owned drug maker Aptalis for $2.9 billion, Forest said Thursday.
Mylan has launched a generic drug for preventing rejection of transplanted organs, the company said Thursday.
Amneal Pharmaceuticals has appointed Rochelle Fuhrmann as CFO, the generic drug maker said Thursday.
Generic drug maker Mylan has hired a former Pfizer executive to its executive leadership team.
Japanese drug maker Daiichi Sankyo is seeking Food and Drug Administration approval for a once-daily tablet to reduce the risk of stroke in patients with atrial fibrillation and treatment of other conditions.
The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said.